Hydroxypropylcellulose in oral drug delivery

ACS Symposium Series

Volumn 934, Issue , 2006, Pages 57-75

  Francis, Mira F ^a   Piredda, Mariella ^a   Winnik, Françoise M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36949019979     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-2006-0934.ch003     Document Type: Conference Paper

References (69)

1. Alvarez-Lorenzo, C., Gomez-Amoza, J. L., Martinez-Pacheco, R., Souto, C. and Concheiro, A. Interactions between hydroxypropylcelluloses and vapour/liquid water. Eur. J. Pharm. Biopharm. 2000, 50, 307-318.
2. Winnik, F. M. Effect of temperature on aqueous solutions of pyrene-labeled (hydroxypropyl)cellulose. Macromolecules 1987, 20, 2745-2750.
3. Final report on the safety assessment of hydroxyethylcellulose, hydroxypropylcellulose, methylcellulose, hydroxypropyl methylcellulose and cellulose gum. J. Am. Coll. Toxicol. 1986, 5, 1-60.
4. Obara, S., Muto, H., Kokubo, H., Ichikawa, N., Kawanabe, M. and Tanaka, O. Primary dermal and eye irritability tests of hydrophobically modified hydroxypropyl methylcellulose in rabbits. J. Toxicol. Sci. 1992, 17, 21-29.
5. FAO/WHO Evaluation of certain food additives and contaminants: thirty-fifth report of the joint FAO/WHO expert committee on food additives. Tech. Rep. Ser. Wld. Hlth. Org. 1990, No. 789.
6. Joneja, S. K., Harcum, W. W., Skinner, G. W., Barnum, P. E. and Guo, J. H. Investigating the fundamental effects of binders on pharmaceutical tablet performance. Drug Dev. Ind. Pharm. 1999, 25, 1129-1135.
7. Lee, J. W., Park, J. H. and Robinson, J. R. Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. 2000, 89, 850-866.
8. Repka, M. A. and McGinity, J. W. Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. J. Control. Release 2001, 70, 341-351.
9. Machida, Y. and Nagai, T. Directly compressed tablets containing hydroxypropyl cellulose in addition to starch or lactose. Chem. Pharm. Bull. 1974, 22, 2346-2351.
10. Alderman, D. A. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. Tech. Prod. Mfr. 1984, 5, 1-9.
11. Skinner, G. W., Harcum, W. W., Barnum, P. E. and Guo, J. H. The evaluation of fine particle hydroxypropylcellulose as a roller compaction binder in pharmaceutical applications. Drug. Dev. Ind. Pharm. 1999, 25, 1121-1128.
12. Huber, H. E., Dale, L. B. and Christenson, G. L. Utilization of hydrophilic gums for the control of drug release from tablet formulations. 1. Disintegration and dissolution behavior. J. Pharm. Sci. 1966, 55, 974-976.
13. Al-Hmoud, H. L., Efentakis, M. and Choulis, N. H. A controlled release matrix using a mixture of hydrophilic and hydrophobic polymers. Int. J. Pharm. 1991, 68, R1-R3.
14. Rao, K. V. R., Devi, K. P. and Buri, P. Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm. 1988, 14, 2299-2320.
15. Skoug, J. W., Mikelsons, M. V., Vigneron, C. N. and Stemm, N. L. Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release. J. Control. Release 1993, 27, 227-245.
16. Ebube, N. K. and Jones, A. B. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers. Int. J. Pharm. 2004, 272, 19-27.
17. Pham, A. T. and Lee, P. I. Probing the mechanisms of drug release from hydroxypropylmethyl cellulose matrices. Pharm. Res. 1994, 11, 1379-1384.
18. Elkheshen, S., Yassin, A. E. and Alkhaled, F. Per-oral extended-release bioadhesive tablet formulation of verapamil HCl. Boll. Chim. Farm. 2003, 142, 226-231.
19. Hosny, E. A., Elkheshen, S. A. and Saleh, S. I. Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies. Boll. Chim. Farm. 2002, 141, 210-217.
20. Celebi, N. and Kislal, O. Development and evaluation of a buccoadhesive propranolol tablet formulation. Pharmazie 1995, 50, 470-472.
21. Gene, L., Oguzlar, C. and Guler, E. Studies on vaginal bioadhesive tablets of acyclovir. Pharmazie 2000, 55, 297-299.
22. Laupacis, A., Keown, P., Ulan, R., McKenzie, N. and Stiller, C. Cyclosporin A: A powerfull immunosuppressant. Can. Med. Assoc. J. 1982, 126, 1041-1046.
23. Ueda, K., Sakagami, H., Ohtaguro, K. and Masui, Y. Studies on the retention of the mucous-membrane-adhesive anticancer agent hydroxypropylcellulose doxorubicin. Eur. Urol. 1992, 21, 250-252.
24. Eiamtrakarn, S., Itoh, Y., Kishimoto, J., Yoshikawa, Y., Shibata, N., Murakami, M. and Takada, K. Gastrointestinal mucoadhesive patch system (Gl-MAPS) for oral administration of G-CSF, a model protein. Biomaterials 2002, 23, 145-152.
25. Klug, E. D. Some properties of water-soluble hydroxyalkyl celluloses and their derivatives. J. Polymer Sci.: PART C 1971, 36, 491-508.
26. Francis, M. F., Piredda, M. and Winnik, F. M. Solubilization of poorly water soluble drugs in micelles of hydrophobically modified hydroxypropylcellulose copolymers. J. Control. Release 2003, 93, 59-68.
27. Francis, M. F., Piredda, M., Cristea, M. and Winnik, F. M. Synthesis and evaluation of hydrophobically-modified polysaccharides as oral delivery vehicles of poorly-water soluble drugs. Polymeric Materials: Science & Engineering 2003, 89, 55-56.
28. Blakeslee, D. Immunofluorescence using dichlorotriazinylaminofluorescein (DTAF). II. Preparation, purity and stability of the compound. J. Immunol. Methods 1977, 17, 361-364.
29. Hofland, H. E. J., Bouwstra, J. A., Verhoef, J. C., Buckton, G., Chowdry, B. Z., Ponec, M. and Junginger, H. E. Safety aspects of non-ionic surfactant vesicles-a toxicity study related to the physicochemical characteristics of non-ionic surfactants. J. Pharm. Pharmacol. 1992, 44, 287-294.
30. Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B. and D'Emanuele, A. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm. Res. 2003, 20, 1543-1550.
31. Zhao, C. L., Winnik, M. A., Riess, G. and Croucher, M. D. Fluorescence probe techniques used to study micelle formation in water-soluble block copolymers. Langmuir 1990, 6, 514-516.
32. Francis, M. F., Cristea, M., Winnik, F. M. and Leroux, J. C. Dextran-g-Polyethyleneglycolcetyl Ether Polymeric Micelles For Oral Delivery of Cyclosporin A. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 2003, 30, 68-69.
33. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
34. Hansen, M. B., Nielsen, S. E. and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989, 119, 203-210.
35. Audus, K. L., Bartel, R. L., Hidalgo, I. J. and Borchardt, R. T. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm. Res. 1990, 7, 435-451.
36. Yee, S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man: fact or myth. Pharm. Res. 1997, 14, 763-766.
37. Hunter, J. and Hirst, B. H. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv. Drug Deliv. Rev. 1997, 25, 129-157.
38. Hosoya, K. I., Kim, K. J. and Lee, V. H. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm. Res. 1996, 13, 885-890.
39. Sovak, M. and Ranganathan, R. Stability of nonionic water-soluble contrast media: implications for their design. Invest. Radiol. 1980, 15, S323-S328.
40. Cavallaro, G., Pitarresi, G., Licciardi, M. and Giammona, G. Polymeric prodrug for release of an antitumoral agent by specific enzymes. Bioconjug. Chem. 2001, 12, 143-151.
41. Oishi, M., Sasaki, S., Nagasaki, Y. and Kataoka, K. pH-responsive oligodeoxynucleotide (ODN)-poly(ethylene glycol) conjugate through acid-labile beta-thiopropionate linkage: preparation and polyion complex micelle formation. Biomacromolecules 2003, 4, 1426-1432.
42. Gao, Z. and Eisenberg, A. A model of micellization for block copolymers in solution. Macromolecules 1993, 26, 7353-7360.
43. Carr, K. E., Hazzard, R. A., Reid, S. and Hodges, G. M. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm. Res. 1996, 13, 1205-1209.
44. Florence, A. T. and Hussain, N. Trancytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv. Drug Deliv. Rev. 2001, 50, S69-S89.
45. Hu, C. and Rhodes, D. G. Proniosomes: a novel drug carrier preparation. Int. J. Pharm. 1999, 185, 23-35.
46. Ozpolat, B., Lopez-Berestein, G., Adamson, P., Fu, C. J. and Williams, A. H. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. J. Pharm. Pharm. Sci. 2003, 6, 292-301.
47. Manjunath, K., Reddy, J. S. and Venkateswarlu, V. Solid lipid nanoparticles as drug delivery systems. Methods Find. Exp. Clin. Pharmacol. 2005, 27, 127-144.
48. Zuccari, G., Carosio, R., Fini, A., Montaldo, P. G. and Orienti, I. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles. J. Control. Release 2005, 103, 369-380.
49. Couch, N. P. The clinical status of low molecular weight dextran: a critical review. Clin. Pharmacol. Ther. 1965, 6, 656-665.
50. Dimitrijevic, D., Shaw, A. J. and Florence, A. T. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. J. Pharm. Pharmacol. 2000, 52, 157-162.
51. Krishna, G., Chen, K. J., Lin, C. C. and Nomeir, A. A. Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. Int. J. Pharm. 2001, 222, 77-89.
52. Delie, F. and Werner, R. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 1997, 14, 221-286.
53. Hidalgo, I. J., Raub, T. J. and Borchardt, R. T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96, 736-749.
54. Artursson, P., Palm, K. and Luthman, K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 2001, 46, 27-43.
55. Artursson, P. and Borchardt, R. T. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm. Res. 1997, 14, 1655-1658.
56. Kamm, W., Jonczyk, A., Jung, T., Luckenbach, G., Raddatz, P. and Kissel, T. Evaluation of absorption enhancement for a potent cyclopeptidic alpha(nu)beta(3)-antagonist in a human intestinal cell line (Caco-2). Eur. J. Pharm. Sci. 2000, 10, 205-214.
57. Faassen, F., Kelder, J., Lenders, J., Underwater, R. and Vromans, H. Physicochemical properties and transport of steroids across Caco-2 cells. Pharm. Res. 2003, 20, 177-186.
58. Woodcock, D. M., Linsenmeyer, M. E., Chojnowski, G., Kriegler, A. B., Nink, V., Webster, L. K. and Sawyer, W. H. Reversal of multidrug resistance by surfactants. Br. J. Cancer 1992, 66, 62-68.
59. Nerurkar, M. M., Burton, P. S. and Borchardt, R. T. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm. Res. 1996, 13, 528-534.
60. Seeballuck, F., Ashford, M. B. and O'Driscoll, C. M. The effects of Pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. Pharm. Res. 2003, 20, 1085-1092.
61. Batrakova, E. V., Han, H. Y., Miller, D. W. and Kabanov, A. V. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. 1998, 15, 1525-1532.
62. Batrakova, E., Lee, S., Li, S., Venne, A., Alakhov, V. and Kabanov, A. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm. Res. 1999, 16, 1373-1379.
63. BASF Pluronic P85 block copolymer surfctant. 2002.
64. Batrakova, E. V., Li, S., Miller, D. W. and Kabanov, A. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res. 1999, 16, 1366-1372.
65. Augustijns, P., Bradshaw, T. P., Gan, L. S., Hendren, R. W. and Thakker, D. R. Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport. Biochem. Biophys. Res. Commun. 1993, 197, 360-365.
66. Wiwattanapatapee, R., Carreno-Gomez, B., Malik, N. and Duncan, R. Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system? Pharm. Res. 2000, 17, 991-998.
67. El-Sayed, M., Ginski, M., Rhodes, C. and Ghandehari, H. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J. Control. Release 2002, 81, 355-365.
68. El-Sayed, M., Rhodes, C. A., Ginski, M. and Ghandehari, H. Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int. J. Pharm. 2003, 265, 151-157.
69. Francis, M. F., Cristea, M., Yang, Y. and Winnik, F. M. Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin A across Caco-2 cells. Pharm. Res. 2005, 22, 209-219.